Trulieve Cannabis Corp.
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
About Trulieve Cannabis
Medicinal Chemicals & Botanical Products, SIC 2833
Trulieve Cannabis Corp. is a vertically integrated cannabis operator that cultivates, processes, manufactures, and distributes medical and adult-use cannabis products. The company produces cannabis flower, oils, and concentrates through extraction, distillation, and purification methods. It distributes these goods under proprietary brand tiers such as Avenue, Cultivar Collection, Muse, Modern Flower, Momenta, Sweet Talk, Co2lors, and Roll One, while also distributing partner brands. Trulieve serves qualified medical cannabis patients and recreational adult consumers aged 21 and older through retail dispensaries and wholesale channels.
The company concentrates its United States operations within three regional hubs located in the Southeast, Northeast, and Southwest. As of December 31, 2025, Trulieve operates 233 dispensaries and 15 cultivation and processing facilities across nine states, including Florida, Arizona, Pennsylvania, West Virginia, Ohio, Georgia, Maryland, Connecticut, and Colorado. The company's corporate head office is located in Tallahassee, Florida, with a registered office in Vancouver, British Columbia.
Summary of the business section of Trulieve Cannabis's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Trulieve Cannabis Corp.
- Founded
- 1940
- Headquarters
- Tallahassee, FL
- Address
- 3494 Martin Hurst Road 32312
- Phone
- (850) 298-8866
- Employees
- 5,000, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- Marcum LLP, West Palm Beach, FL
Stock & identifiers
- Ticker
- TRLV
- Exchange
- NYSE
- IPO date
- Apr 8, 2021
- Shares outstanding
- 193M, Jul 31, 2026
- Public float
- $600.00M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1754195
- CUSIP
- 89788C104
- ISIN
- US89788C1045
- EIN
- 58-1882476
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Kim A. Rivers | Chairman and CEO, Director | 1,476,913 |
| Brett R. Walsh | Chief Accounting Officer | 140,305 |
| Christine Ann Hersey | Chief Corp Affairs & Strategy | 143,767 |
| Jan Reese | Chief Financial Officer | 58,594 |
| Jason Pernell | President | 581,795 |
| Nilyum Jhala | Chief Technology Officer | 246,254 |
| Eric Powers | Chief Legal Officer | 246,311 |
| Kyle Landrum | Chief Production Officer | 258,776 |
| Timothy Morey | Chief Sales Officer | 174,709 |
| Joy Malivuk | Chief Accounting Officer | 74,289 |
| Gina Collins | Chief Marketing Officer | 188,916 |
| Ryan Blust | Interim CFO | 77,038 |
| Marie Zhang | Chief Operating Officer | 58,800 |
| Wes Getman | Chief Financial Officer | 47,000 |
| Richard S. May | Director | 593,534 |
| Matthew J. Foulston | Director | 34,767 |
| Thomas L. Millner | Director | 72,543 |
| Susan Thronson | Director | 74,283 |
| Thad Beshears | Director | 5,487,043 |
| Jane Cecil Morreau | Director | 65,778 |
| Peter Healy | Director | 72,673 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Kim Rivers | $7.59M | $11.72M | $879.87K | $27 | $27 |
| FY2024 Kim Rivers | $5.14M | $3.49M | $1.64M | $16 | $22 |
| FY2023 Kim Rivers | $3.36M | $3.77M | $682.28K | $16 | $36 |
| FY2022 Kim Rivers | $3.90M | -$656.15K | $1.36M | $24 | $33 |
| FY2021 Kim Rivers | $8.05M | $7.14M | $2.05M | $82 | $79 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had over 5,000 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 7, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 9, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jun 4, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 29, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Feb 24, 2023 | Late filing | Notification of late filing |
| Oct 1, 2021 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 7, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 8, 2021 | IPO | Initial public offering priced (424B4 prospectus) |